Sela M

General

Full name : Michael Sela

First name : Michael

Mail : Department of Immunology, Weizmann Institute of Science, Rehovot 76100

Zip Code :

City :

Country : Israel

Email : michael.sela@weizmann.ac.il

Phone :

Fax :

Website :

Directory :

Comment

References (4)

Title : Multimerization of ERBB2\/HER2 specific aptamer leads to improved receptor binding - Mahlknecht_2015_Biochem.Biophys.Res.Commun_465_218
Author(s) : Mahlknecht G , Maron R , Schechter B , Yarden Y , Sela M
Ref : Biochemical & Biophysical Research Communications , 465 :218 , 2015
Abstract :
PubMedSearch : Mahlknecht_2015_Biochem.Biophys.Res.Commun_465_218
PubMedID: 26248137

Title : Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR - Ferraro_2013_Proc.Natl.Acad.Sci.U.S.A_110_1815
Author(s) : Ferraro DA , Gaborit N , Maron R , Cohen-Dvashi H , Porat Z , Pareja F , Lavi S , Lindzen M , Ben-Chetrit N , Sela M , Yarden Y
Ref : Proc Natl Acad Sci U S A , 110 :1815 , 2013
Abstract :
PubMedSearch : Ferraro_2013_Proc.Natl.Acad.Sci.U.S.A_110_1815
PubMedID: 23319610

Title : Aptamer to ErbB-2\/HER2 enhances degradation of the target and inhibits tumorigenic growth - Mahlknecht_2013_Proc.Natl.Acad.Sci.U.S.A_110_8170
Author(s) : Mahlknecht G , Maron R , Mancini M , Schechter B , Sela M , Yarden Y
Ref : Proc Natl Acad Sci U S A , 110 :8170 , 2013
Abstract :
PubMedSearch : Mahlknecht_2013_Proc.Natl.Acad.Sci.U.S.A_110_8170
PubMedID: 23630281

Title : Inhibition of pancreatic carcinoma by homo- and heterocombinations of antibodies against EGF-receptor and its kin HER2\/ErbB-2 - Maron_2013_Proc.Natl.Acad.Sci.U.S.A_110_15389
Author(s) : Maron R , Schechter B , Mancini M , Mahlknecht G , Yarden Y , Sela M
Ref : Proc Natl Acad Sci U S A , 110 :15389 , 2013
Abstract :
PubMedSearch : Maron_2013_Proc.Natl.Acad.Sci.U.S.A_110_15389
PubMedID: 24003140